Merging ligand-based and structure-based methods in drug discovery: An overview of combined virtual screening approaches
Virtual screening (VS) is an outstanding cornerstone in the drug discovery pipeline. A variety
of computational approaches, which are generally classified as ligand-based (LB) and …
of computational approaches, which are generally classified as ligand-based (LB) and …
Combination of similarity rankings using data fusion
P Willett - Journal of chemical information and modeling, 2013 - ACS Publications
Similarity searching is one of the most common techniques for ligand-based virtual
screening and involves scanning a chemical database to identify those molecules that are …
screening and involves scanning a chemical database to identify those molecules that are …
Bioactive molecule prediction using extreme gradient boosting
I Babajide Mustapha, F Saeed - Molecules, 2016 - mdpi.com
Following the explosive growth in chemical and biological data, the shift from traditional
methods of drug discovery to computer-aided means has made data mining and machine …
methods of drug discovery to computer-aided means has made data mining and machine …
A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields
F Broccatelli, E Carosati, A Neri, M Frosini… - Journal of medicinal …, 2011 - ACS Publications
P-glycoprotein (Pgp or ABCB1) is an ABC transporter protein involved in intestinal
absorption, drug metabolism, and brain penetration, and its inhibition can seriously alter a …
absorption, drug metabolism, and brain penetration, and its inhibition can seriously alter a …
Computational polypharmacology: a new paradigm for drug discovery
Introduction: Over the past couple of years, the cost of drug development has sharply
increased along with the high rate of clinical trial failures. Such increase in expenses is …
increased along with the high rate of clinical trial failures. Such increase in expenses is …
Design, synthesis, and biological activity of new CB2 receptor ligands: From orthosteric and allosteric modulators to dualsteric/bitopic ligands
The design of dualsteric/bitopic agents as single chemical entities able to simultaneously
interact with both the orthosteric and an allosteric binding site represents a novel approach …
interact with both the orthosteric and an allosteric binding site represents a novel approach …
From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling
MPA Sanders, R McGuire, L Roumen, IJP de Esch… - …, 2012 - pubs.rsc.org
A pharmacophore describes the arrangement of molecular features a ligand must contain to
efficaciously bind a receptor. Pharmacophore models are developed to improve molecular …
efficaciously bind a receptor. Pharmacophore models are developed to improve molecular …
[HTML][HTML] Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum …
J Desantis, A Bazzacco, M Eleuteri, S Tuci… - European Journal of …, 2024 - Elsevier
Abstract To date, Proteolysis Targeting Chimera (PROTAC) technology has been
successfully applied to mediate proteasomal-induced degradation of several …
successfully applied to mediate proteasomal-induced degradation of several …
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
L Costantino, S Ferrari, M Santucci, OMH Salo-Ahen… - Elife, 2022 - elifesciences.org
Drugs that target human thymidylate synthase (hTS), a dimeric enzyme, are widely used in
anticancer therapy. However, treatment with classical substrate-site-directed TS inhibitors …
anticancer therapy. However, treatment with classical substrate-site-directed TS inhibitors …
From laptop to benchtop to bedside: structure-based drug design on protein targets
As an important aspect of computer-aided drug design, structure-based drug design brought
a new horizon to pharmaceutical development. This in silico method permeates all aspects …
a new horizon to pharmaceutical development. This in silico method permeates all aspects …